0 XP   0   0   0

WOCKHARDT LTD.
Buy, Hold or Sell?

Should you buy, hold or sell Wockhardt?

I guess you are interested in WOCKHARDT LTD.. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

Let's analyse Wockhardt

Let's start. I'm going to help you getting a better view of WOCKHARDT LTD.. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

  1. Company's Financial Health
    A deep dive into the books. How are the numbers doing? Is WOCKHARDT LTD. even making a profit? Is the company skyrocketing? Or is it sinking like the Titanic. The trend is your friend.
  2. Market Valuation
    Finally, you now have an insight of how WOCKHARDT LTD. is doing in the market. If the company is worth buying. The latest step is to find out how other investors value WOCKHARDT LTD.. The closing price on 2023-01-27 was INR197.85 per share. Is the company over- or underpriced?
  3. Key Performance Indicators
    A total overlook on how the company is doing. Based on the (trends in) the key performance indicators.
WOCKHARDT LTD. Daily Candlestick Chart
WOCKHARDT LTD. Daily Candlestick Chart
Summary









1. Valuation of Wockhardt




Current price per share

INR197.85

2. Growth of Wockhardt




Is Wockhardt growing?

Current yearPrevious yearGrowGrow %
How rich?$516.8m$462.5m$54.3m10.5%

How much money is Wockhardt making?

Current yearPrevious yearGrowGrow %
Making money-$30m$84.3m-$114.3m-381.2%
Net Profit Margin-7.6%25.4%--

How much money comes from the company's main activities?

3. Financial Health of Wockhardt




Comparing to competitors in the Drug Manufacturers-Specialty & Generic industry




  Industry Rankings (Drug Manufacturers-Specialty & Generic)  


Richest
#72 / 705

Most Revenue
#69 / 705

Most Profit
#694 / 705

Most Efficient
#445 / 705


Summary

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is just not able to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is able to pay all its debts with equity.

1.1. Profitability of WOCKHARDT LTD..

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Wockhardt earns for each ₹1 of revenue.

  • Above 10% is considered healthy but always compare Wockhardt to the Drug Manufacturers-Specialty & Generic industry mean.
  • A Net Profit Margin of -7.6% means that ₹-0.08 for each ₹1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of WOCKHARDT LTD.:

  • The MRQ is -7.6%. The company is making a loss. -1
  • The TTM is -7.6%. The company is making a loss. -1
Trends
Current periodCompared to+/- 
MRQ-7.6%TTM-7.6%0.0%
TTM-7.6%YOY25.4%-33.0%
TTM-7.6%5Y-1.0%-6.6%
5Y-1.0%10Y2.5%-3.4%
Compared to industry (Drug Manufacturers-Specialty & Generic)
PeriodCompanyIndustry (mean)+/- 
MRQ-7.6%0.4%-8.0%
TTM-7.6%0.3%-7.9%
YOY25.4%0.2%+25.2%
5Y-1.0%-0.7%-0.3%
10Y2.5%-0.1%+2.6%
1.1.2. Return on Assets

Shows how efficient Wockhardt is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Wockhardt to the Drug Manufacturers-Specialty & Generic industry mean.
  • -3.0% Return on Assets means that Wockhardt generated ₹-0.03 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of WOCKHARDT LTD.:

  • The MRQ is -3.0%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -3.0%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-3.0%TTM-3.0%0.0%
TTM-3.0%YOY8.8%-11.8%
TTM-3.0%5Y-1.0%-2.0%
5Y-1.0%10Y1.6%-2.6%
Compared to industry (Drug Manufacturers-Specialty & Generic)
PeriodCompanyIndustry (mean)+/- 
MRQ-3.0%0.1%-3.1%
TTM-3.0%0.1%-3.1%
YOY8.8%-0.1%+8.9%
5Y-1.0%-0.2%-0.8%
10Y1.6%0.1%+1.5%
1.1.3. Return on Equity

Shows how efficient Wockhardt is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Wockhardt to the Drug Manufacturers-Specialty & Generic industry mean.
  • -6.3% Return on Equity means Wockhardt generated ₹-0.06 for each ₹1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of WOCKHARDT LTD.:

  • The MRQ is -6.3%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -6.3%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-6.3%TTM-6.3%0.0%
TTM-6.3%YOY20.3%-26.7%
TTM-6.3%5Y-3.4%-2.9%
5Y-3.4%10Y2.3%-5.8%
Compared to industry (Drug Manufacturers-Specialty & Generic)
PeriodCompanyIndustry (mean)+/- 
MRQ-6.3%0.6%-6.9%
TTM-6.3%0.4%-6.7%
YOY20.3%0.4%+19.9%
5Y-3.4%-0.3%-3.1%
10Y2.3%0.1%+2.2%

1.2. Operating Efficiency of WOCKHARDT LTD..

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Wockhardt is operating .

  • Measures how much profit Wockhardt makes for each ₹1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Wockhardt to the Drug Manufacturers-Specialty & Generic industry mean.
  • An Operating Margin of 0.0% means the company generated ₹0.00  for each ₹1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of WOCKHARDT LTD.:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y-2.8%+2.8%
5Y-2.8%10Y2.7%-5.4%
Compared to industry (Drug Manufacturers-Specialty & Generic)
PeriodCompanyIndustry (mean)+/- 
MRQ-2.5%-2.5%
TTM-1.6%-1.6%
YOY-2.7%-2.7%
5Y-2.8%1.8%-4.6%
10Y2.7%0.8%+1.9%
1.2.2. Operating Ratio

Measures how efficient Wockhardt is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Drug Manufacturers-Specialty & Generic industry mean).
  • An Operation Ratio of 1.38 means that the operating costs are ₹1.38 for each ₹1 in net sales.

Let's take a look of the Operating Ratio trends of WOCKHARDT LTD.:

  • The MRQ is 1.379. The company is inefficient in keeping operating costs low. -1
  • The TTM is 1.379. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.379TTM1.3790.000
TTM1.379YOY1.525-0.146
TTM1.3795Y1.465-0.087
5Y1.46510Y1.392+0.073
Compared to industry (Drug Manufacturers-Specialty & Generic)
PeriodCompanyIndustry (mean)+/- 
MRQ1.3791.473-0.094
TTM1.3791.456-0.077
YOY1.5251.398+0.127
5Y1.4651.374+0.091
10Y1.3921.191+0.201

1.3. Liquidity of WOCKHARDT LTD..

1.3. Liquidity
1.3.1. Current Ratio

Measures if Wockhardt is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Drug Manufacturers-Specialty & Generic industry mean).
  • A Current Ratio of 0.81 means the company has ₹0.81 in assets for each ₹1 in short-term debts.

Let's take a look of the Current Ratio trends of WOCKHARDT LTD.:

  • The MRQ is 0.807. The company is just not able to pay all its short-term debts. -1
  • The TTM is 0.807. The company is just not able to pay all its short-term debts. -1
Trends
Current periodCompared to+/- 
MRQ0.807TTM0.8070.000
TTM0.807YOY0.777+0.030
TTM0.8075Y0.904-0.096
5Y0.90410Y1.430-0.526
Compared to industry (Drug Manufacturers-Specialty & Generic)
PeriodCompanyIndustry (mean)+/- 
MRQ0.8071.880-1.073
TTM0.8071.901-1.094
YOY0.7772.112-1.335
5Y0.9042.182-1.278
10Y1.4301.891-0.461
1.3.2. Quick Ratio

Measures if Wockhardt is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Wockhardt to the Drug Manufacturers-Specialty & Generic industry mean.
  • A Quick Ratio of 0.29 means the company can pay off ₹0.29 for each ₹1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of WOCKHARDT LTD.:

  • The MRQ is 0.289. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.289. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.289TTM0.2890.000
TTM0.289YOY0.296-0.007
TTM0.2895Y0.385-0.096
5Y0.38510Y0.545-0.161
Compared to industry (Drug Manufacturers-Specialty & Generic)
PeriodCompanyIndustry (mean)+/- 
MRQ0.2890.733-0.444
TTM0.2890.796-0.507
YOY0.2960.808-0.512
5Y0.3850.834-0.449
10Y0.5450.821-0.276

1.4. Solvency of WOCKHARDT LTD..

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Wockhardt assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Wockhardt to Drug Manufacturers-Specialty & Generic industry mean.
  • A Debt to Asset Ratio of 0.49 means that Wockhardt assets are financed with 49.0% credit (debt) and the remaining percentage (100% - 49.0%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of WOCKHARDT LTD.:

  • The MRQ is 0.490. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.490. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.490TTM0.4900.000
TTM0.490YOY0.516-0.026
TTM0.4905Y0.571-0.081
5Y0.57110Y0.534+0.038
Compared to industry (Drug Manufacturers-Specialty & Generic)
PeriodCompanyIndustry (mean)+/- 
MRQ0.4900.437+0.053
TTM0.4900.424+0.066
YOY0.5160.398+0.118
5Y0.5710.398+0.173
10Y0.5340.401+0.133
1.4.2. Debt to Equity Ratio

Measures if Wockhardt is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Wockhardt to the Drug Manufacturers-Specialty & Generic industry mean.
  • A Debt to Equity ratio of 105.0% means that company has ₹1.05 debt for each ₹1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of WOCKHARDT LTD.:

  • The MRQ is 1.050. The company is able to pay all its debts with equity. +1
  • The TTM is 1.050. The company is able to pay all its debts with equity. +1
Trends
Current periodCompared to+/- 
MRQ1.050TTM1.0500.000
TTM1.050YOY1.188-0.138
TTM1.0505Y1.540-0.490
5Y1.54010Y1.344+0.196
Compared to industry (Drug Manufacturers-Specialty & Generic)
PeriodCompanyIndustry (mean)+/- 
MRQ1.0500.652+0.398
TTM1.0500.675+0.375
YOY1.1880.623+0.565
5Y1.5400.684+0.856
10Y1.3440.697+0.647

2. Market Valuation of WOCKHARDT LTD.

2. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every ₹1 in earnings Wockhardt generates.

  • Above 15 is considered overpriced but always compare Wockhardt to the Drug Manufacturers-Specialty & Generic industry mean.
  • A PE ratio of -15.58 means the investor is paying ₹-15.58 for every ₹1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of WOCKHARDT LTD.:

  • The EOD is -11.681. Company is losing money. -2
  • The MRQ is -15.575. Company is losing money. -2
  • The TTM is -15.575. Company is losing money. -2
Trends
Current periodCompared to+/- 
EOD-11.681MRQ-15.575+3.894
MRQ-15.575TTM-15.5750.000
TTM-15.575YOY7.260-22.836
TTM-15.5755Y-14.880-0.695
5Y-14.88010Y-1.680-13.201
Compared to industry (Drug Manufacturers-Specialty & Generic)
PeriodCompanyIndustry (mean)+/- 
EOD-11.681-0.124-11.557
MRQ-15.575-0.437-15.138
TTM-15.575-0.102-15.473
YOY7.26015.340-8.080
5Y-14.8807.916-22.796
10Y-1.6807.700-9.380
2.2. Price Earnings to Growth Ratio

Measures the predicted future growth of Wockhardt.

  • Lower is better.
  • A PEG ratio of 1 means the market price of the stock and the expected future earnings are on par.

Let's take a look of the Price Earnings to Growth Ratio trends of WOCKHARDT LTD.:

  • The MRQ is 52.479. Seems overpriced? -1
  • The TTM is 52.479. Seems overpriced? -1
Trends
Current periodCompared to+/- 
MRQ52.479TTM52.4790.000
TTM52.479YOY0.652+51.827
TTM52.4795Y6.649+45.830
5Y6.64910Y32.599-25.950
Compared to industry (Drug Manufacturers-Specialty & Generic)
PeriodCompanyIndustry (mean)+/- 
MRQ52.4790.012+52.467
TTM52.4790.010+52.469
YOY0.6520.004+0.648
5Y6.6490.010+6.639
10Y32.5990.021+32.578

2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Wockhardt is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Drug Manufacturers-Specialty & Generic industry mean).
  • A PB ratio of 0.90 means the investor is paying ₹0.90 for each ₹1 in book value.

Let's take a look of the Price to Book Ratio trends of WOCKHARDT LTD.:

  • The EOD is 0.678. Very good. +2
  • The MRQ is 0.904. Very good. +2
  • The TTM is 0.904. Very good. +2
Trends
Current periodCompared to+/- 
EOD0.678MRQ0.904-0.226
MRQ0.904TTM0.9040.000
TTM0.904YOY1.325-0.420
TTM0.9045Y1.401-0.496
5Y1.40110Y2.045-0.644
Compared to industry (Drug Manufacturers-Specialty & Generic)
PeriodCompanyIndustry (mean)+/- 
EOD0.6781.415-0.737
MRQ0.9041.586-0.682
TTM0.9042.019-1.115
YOY1.3252.230-0.905
5Y1.4011.895-0.494
10Y2.0451.505+0.540
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of WOCKHARDT LTD. compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---21.108-21.1080%36.741-157%-8.813-58%32.409-165%
Book Value Growth--1.1171.1170%1.230-9%1.033+8%1.022+9%
Book Value Per Share--291.684291.6840%312.792-7%288.108+1%315.917-8%
Book Value Per Share Growth--0.9330.9330%1.133-18%0.977-5%0.987-6%
Current Ratio--0.8070.8070%0.777+4%0.904-11%1.430-44%
Debt To Asset Ratio--0.4900.4900%0.516-5%0.571-14%0.534-8%
Debt To Equity Ratio--1.0501.0500%1.188-12%1.540-32%1.344-22%
Dividend Per Share--0.1390.1390%0.044+215%0.039+258%5.515-97%
Dividend Per Share Growth--3.1493.1490%--0.837+276%99.393-97%
Eps---16.937-16.9370%57.069-130%-7.721-54%8.758-293%
Eps Growth---0.297-0.2970%11.131-103%2.610-111%1.671-118%
Free Cash Flow Per Share--13.95313.9530%-37.686+370%-2.109+115%-2.899+121%
Free Cash Flow Per Share Growth--2.3702.3700%-0.876+137%2.393-1%1.169+103%
Free Cash Flow To Equity Per Share--13.95313.9530%-37.686+370%-42.296+403%-16.881+221%
Free Cash Flow To Equity Per Share Growth--2.3702.3700%-0.056+102%0.693+242%1.188+100%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max--489.302--------
Intrinsic Value_10Y_min--407.930--------
Intrinsic Value_1Y_max--21.564--------
Intrinsic Value_1Y_min--20.953--------
Intrinsic Value_3Y_max--85.724--------
Intrinsic Value_3Y_min--80.586--------
Intrinsic Value_5Y_max--175.122--------
Intrinsic Value_5Y_min--159.083--------
Net Profit Margin---0.076-0.0760%0.254-130%-0.010-87%0.025-405%
Operating Margin----0%-0%-0.0280%0.027-100%
Operating Ratio--1.3791.3790%1.525-10%1.465-6%1.392-1%
Pb Ratio0.678-33%0.9040.9040%1.325-32%1.401-35%2.045-56%
Pe Ratio-11.681+25%-15.575-15.5750%7.260-315%-14.880-4%-1.680-89%
Peg Ratio--52.47952.4790%0.652+7946%6.649+689%32.599+61%
Price Per Share197.850-33%263.800263.8000%414.350-36%404.040-35%670.600-61%
Price To Total Gains Ratio-9.435+25%-12.580-12.5800%11.264-212%-1.188-91%6.244-301%
Profit Growth---0.356-0.3560%11.911-103%2.754-113%1.762-120%
Quick Ratio--0.2890.2890%0.296-2%0.385-25%0.545-47%
Return On Assets---0.030-0.0300%0.088-134%-0.010-67%0.016-283%
Return On Equity---0.063-0.0630%0.203-131%-0.034-46%0.023-370%
Revenue Growth--1.1891.1890%0.953+25%0.972+22%0.960+24%
Total Gains Per Share---20.970-20.9700%36.785-157%-8.774-58%37.925-155%
Total Gains Per Share Growth---0.570-0.5700%7.712-107%2.337-124%1.471-139%
Usd Book Value--516846000.000516846000.0000%462510750.000+12%423666612.000+22%447696220.000+15%
Usd Book Value Change Per Share---0.260-0.2600%0.452-157%-0.108-58%0.399-165%
Usd Book Value Per Share--3.5883.5880%3.847-7%3.544+1%3.886-8%
Usd Dividend Per Share--0.0020.0020%0.001+215%0.000+258%0.068-97%
Usd Eps---0.208-0.2080%0.702-130%-0.095-54%0.108-293%
Usd Free Cash Flow--24723000.00024723000.0000%-55725150.000+325%-2607354.000+111%-1448530.000+106%
Usd Free Cash Flow Per Share--0.1720.1720%-0.464+370%-0.026+115%-0.036+121%
Usd Free Cash Flow To Equity Per Share--0.1720.1720%-0.464+370%-0.520+403%-0.208+221%
Usd Price Per Share2.434-33%3.2453.2450%5.097-36%4.970-35%8.248-61%
Usd Profit---30012000.000-30012000.0000%84385380.000-136%-10577754.000-65%11898610.000-352%
Usd Revenue--394830000.000394830000.0000%332002830.000+19%413749368.000-5%472850403.333-17%
Usd Total Gains Per Share---0.258-0.2580%0.452-157%-0.108-58%0.466-155%
 EOD+3 -2MRQTTM+0 -0YOY+19 -215Y+20 -2110Y+16 -26

3.2. Fundamental Score

Let's check the fundamental score of WOCKHARDT LTD. based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-11.681
Price to Book Ratio (EOD)Between0-10.678
Net Profit Margin (MRQ)Greater than0-0.076
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than10.289
Current Ratio (MRQ)Greater than10.807
Debt to Asset Ratio (MRQ)Less than10.490
Debt to Equity Ratio (MRQ)Less than11.050
Return on Equity (MRQ)Greater than0.15-0.063
Return on Assets (MRQ)Greater than0.05-0.030
Total2/10 (20.0%)

3.3. Technical Score

Let's check the technical score of WOCKHARDT LTD. based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
OpenGreater thanClose205.650
Total1/1 (100.0%)



Reversals in quarterly reports

I have detected a reversal (positive to negative, negative to positive) in the following values of the quarterly reports.

 2018-03-312019-03-312020-03-312021-03-312022-03-31
Operating Income  -2,049,6001,738,700-310,900-952,900-1,263,800-1,544,700-2,808,5003,318,500510,000



Latest Balance Sheet

Balance Sheet of 2022-03-31. Currency in INR. All numbers in thousands.

Summary
Total Assets82,430,000
Total Liabilities40,410,000
Total Stockholder Equity38,490,000
 As reported
Total Liabilities 40,410,000
Total Stockholder Equity+ 38,490,000
Total Assets = 82,430,000

Assets

Total Assets82,430,000
Total Current Assets25,890,000
Long-term Assets25,890,000
Total Current Assets
Cash And Cash Equivalents 3,700,000
Short-term Investments 90,000
Net Receivables 9,180,000
Inventory 7,690,000
Other Current Assets 3,400,000
Total Current Assets  (as reported)25,890,000
Total Current Assets  (calculated)24,060,000
+/- 1,830,000
Long-term Assets
Goodwill 8,910,000
Intangible Assets 10,530,000
Long-term Assets Other 1,030,000
Long-term Assets  (as reported)56,540,000
Long-term Assets  (calculated)20,470,000
+/- 36,070,000

Liabilities & Shareholders' Equity

Total Current Liabilities32,070,000
Long-term Liabilities8,340,000
Total Stockholder Equity38,490,000
Total Current Liabilities
Short Long Term Debt 15,070,000
Accounts payable 9,210,000
Other Current Liabilities 1,010,000
Total Current Liabilities  (as reported)32,070,000
Total Current Liabilities  (calculated)25,290,000
+/- 6,780,000
Long-term Liabilities
Long term Debt 3,550,000
Capital Lease Obligations Min Short Term Debt3,360,000
Long-term Liabilities  (as reported)8,340,000
Long-term Liabilities  (calculated)6,910,000
+/- 1,430,000
Total Stockholder Equity
Retained Earnings 12,760,000
Total Stockholder Equity (as reported)38,490,000
Total Stockholder Equity (calculated)12,760,000
+/- 25,730,000
Other
Capital Stock720,000
Common Stock Shares Outstanding 144,060
Net Debt 14,920,000
Net Invested Capital 57,110,000
Net Working Capital -6,180,000



Balance Sheet

Currency in INR. All numbers in thousands.

 Trend2022-03-312021-03-312020-03-312019-03-312018-03-312017-03-312016-03-312015-03-312014-03-31
> Total Assets 
66,220,200
69,388,800
81,208,600
89,686,900
81,620,400
78,311,000
81,789,100
77,726,900
82,430,000
82,430,00077,726,90081,789,10078,311,00081,620,40089,686,90081,208,60069,388,80066,220,200
   > Total Current Assets 
33,559,200
35,215,600
39,518,500
45,352,700
33,796,000
28,146,500
24,298,300
24,243,800
25,890,000
25,890,00024,243,80024,298,30028,146,50033,796,00045,352,70039,518,50035,215,60033,559,200
       Cash And Cash Equivalents 
11,258,000
12,345,500
14,781,100
9,636,400
8,972,400
3,973,400
2,193,400
2,322,500
3,700,000
3,700,0002,322,5002,193,4003,973,4008,972,4009,636,40014,781,10012,345,50011,258,000
       Short-term Investments 
5,739,800
3,387,200
0
11,502,200
3,997,600
457,700
457,300
54,400
90,000
90,00054,400457,300457,7003,997,60011,502,20003,387,2005,739,800
       Net Receivables 
4,851,400
7,414,300
11,949,000
10,636,900
9,707,600
12,739,000
12,426,900
9,176,500
9,180,000
9,180,0009,176,50012,426,90012,739,0009,707,60010,636,90011,949,0007,414,3004,851,400
       Inventory 
9,928,900
10,207,800
11,021,600
11,079,500
8,557,100
8,193,600
6,898,300
7,988,800
7,690,000
7,690,0007,988,8006,898,3008,193,6008,557,10011,079,50011,021,60010,207,8009,928,900
       Other Current Assets 
1,781,100
1,860,800
1,766,800
2,499,200
3,102,600
3,037,600
2,691,100
2,385,900
3,400,000
3,400,0002,385,9002,691,1003,037,6003,102,6002,499,2001,766,8001,860,8001,781,100
   > Long-term Assets 
0
0
0
43,526,500
47,824,400
50,296,600
57,490,800
53,483,100
56,540,000
56,540,00053,483,10057,490,80050,296,60047,824,40043,526,500000
       Property Plant Equipment 
20,470,200
23,223,800
28,454,300
29,133,400
29,870,500
30,242,200
33,153,500
0
0
0033,153,50030,242,20029,870,50029,133,40028,454,30023,223,80020,470,200
       Goodwill 
8,502,600
7,145,200
7,930,000
7,365,100
8,405,800
8,205,600
8,751,900
9,040,400
8,910,000
8,910,0009,040,4008,751,9008,205,6008,405,8007,365,1007,930,0007,145,2008,502,600
       Long Term Investments 
26,200
26,200
4,500
4,500
4,500
4,500
0
0
0
0004,5004,5004,5004,50026,20026,200
       Intangible Assets 
1,048,800
931,400
2,063,200
3,666,500
4,929,000
6,586,300
8,962,800
9,037,500
10,530,000
10,530,0009,037,5008,962,8006,586,3004,929,0003,666,5002,063,200931,4001,048,800
       Long-term Assets Other 
0
0
0
43,526,500
47,824,400
521,800
603,700
100
1,030,000
1,030,000100603,700521,80047,824,40043,526,500000
> Total Liabilities 
29,043,800
30,795,800
38,804,100
52,500,400
49,641,600
48,264,700
51,214,500
40,124,400
40,410,000
40,410,00040,124,40051,214,50048,264,70049,641,60052,500,40038,804,10030,795,80029,043,800
   > Total Current Liabilities 
17,432,000
17,729,700
18,418,500
19,788,100
26,917,100
28,636,600
34,971,800
31,182,200
32,070,000
32,070,00031,182,20034,971,80028,636,60026,917,10019,788,10018,418,50017,729,70017,432,000
       Short-term Debt 
19,060,800
4,769,500
2,059,700
9,570,700
15,747,100
14,831,300
0
0
0
00014,831,30015,747,1009,570,7002,059,7004,769,50019,060,800
       Short Long Term Debt 
19,060,800
4,769,500
2,059,700
9,570,700
15,747,100
14,831,300
19,723,300
18,288,800
15,070,000
15,070,00018,288,80019,723,30014,831,30015,747,1009,570,7002,059,7004,769,50019,060,800
       Accounts payable 
5,577,900
5,525,600
6,376,900
5,338,100
6,017,800
8,402,400
8,952,700
5,779,700
9,210,000
9,210,0005,779,7008,952,7008,402,4006,017,8005,338,1006,376,9005,525,6005,577,900
       Other Current Liabilities 
2,824,500
3,065,600
3,357,800
3,610,700
3,558,800
3,148,400
2,380,600
1,741,700
1,010,000
1,010,0001,741,7002,380,6003,148,4003,558,8003,610,7003,357,8003,065,6002,824,500
   > Long-term Liabilities 
0
0
0
33,242,200
22,724,500
19,760,200
16,242,700
8,942,200
8,340,000
8,340,0008,942,20016,242,70019,760,20022,724,50033,242,200000
       Capital Lease Obligations 
0
0
0
0
0
0
3,690,300
3,412,200
3,360,000
3,360,0003,412,2003,690,300000000
> Total Stockholder Equity
32,829,200
34,168,000
37,311,600
33,367,100
28,521,500
26,748,000
26,716,700
33,767,600
38,490,000
38,490,00033,767,60026,716,70026,748,00028,521,50033,367,10037,311,60034,168,00032,829,200
   Common Stock
548,800
550,400
552,500
552,700
553,200
553,400
553,700
0
0
00553,700553,400553,200552,700552,500550,400548,800
   Retained Earnings 
22,591,700
24,187,600
25,642,700
23,153,700
17,277,500
15,260,600
14,521,600
15,291,200
12,760,000
12,760,00015,291,20014,521,60015,260,60017,277,50023,153,70025,642,70024,187,60022,591,700
   Capital Surplus 000000000
   Treasury Stock000000000
   Other Stockholders Equity 
8,954,500
8,534,600
9,703,400
8,630,700
9,600,800
9,592,400
10,257,900
0
0
0010,257,9009,592,4009,600,8008,630,7009,703,4008,534,6008,954,500



Balance Sheet

Currency in INR. All numbers in thousands.




Cash Flow

Currency in INR. All numbers in thousands.




Income Statement

Currency in INR. All numbers in thousands.


Latest Income Statement (annual, 2022-03-31)

Gross Profit (+$)
totalRevenue32,100,000
Cost of Revenue-12,670,000
Gross Profit19,430,00019,430,000
 
Operating Income (+$)
Gross Profit19,430,000
Operating Expense-31,590,000
Operating Income510,000-12,160,000
 
Operating Expense (+$)
Research Development-
Selling General Administrative3,280,000
Selling And Marketing Expenses-
Operating Expense31,590,0003,280,000
 
Net Interest Income (+$)
Interest Income60,000
Interest Expense-2,820,000
Net Interest Income-2,930,000-2,760,000
 
Pretax Income (+$)
Operating Income510,000
Net Interest Income-2,930,000
Other Non-Operating Income Expenses-
Income Before Tax (EBT)-4,110,000510,000
EBIT - interestExpense = -2,820,000
-2,440,000
380,000
Interest Expense2,820,000
Earnings Before Interest and Taxes (ebit)--1,290,000
Earnings Before Interest and Taxes (ebitda)1,180,000
 
After tax Income (+$)
Income Before Tax-4,110,000
Tax Provision--1,320,000
Net Income From Continuing Ops-2,790,000-2,790,000
Net Income-2,440,000
Net Income Applicable To Common Shares-
 
Non-recurring Events
Discontinued Operations-
Extraordinary Items-
Effect of Accounting Charges-
Other Items-
Non Recurring-
Other Operating Expenses-
Total Other Income/Expenses Net-2,930,000
 

Comments

Join the conversation.

Leave a comment

Stay informed with my latest content.

Subscribe to my newsletter and receive an email as soon as I add content to PenkeTrading.com.


By clicking Register, you agree to the General Terms and Conditions.
Penke's Market Notifications
POLY.XETRA
21 minutes ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of POLY.XETRA.

POLY.XETRA Daily Candlestick Chart
ENTEL.SN
24 minutes ago

I found you a Golden Cross on the daily chart of ENTEL.SN.

ENTEL.SN Daily Candlestick Chart
CENCOSUD.SN
25 minutes ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of CENCOSUD.SN.

CENCOSUD.SN Daily Candlestick Chart
ANTARCHILE.SN
25 minutes ago

I found you a Death Cross on the daily chart of ANTARCHILE.SN.

ANTARCHILE.SN Daily Candlestick Chart
3BBE.XETRA
26 minutes ago

I found you a STOCH Bullish Hidden Divergence on the daily chart of 3BBE.XETRA.

3BBE.XETRA Daily Candlestick Chart
FORUS.SN
26 minutes ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of FORUS.SN.

FORUS.SN Daily Candlestick Chart
NGA1L.MI
27 minutes ago

I found you a RSI Bullish Reversal Divergence on the daily chart of NGA1L.MI.

NGA1L.MI Daily Candlestick Chart
3CRE.XETRA
27 minutes ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of 3CRE.XETRA.

3CRE.XETRA Daily Candlestick Chart
GLGI.OTCQB
29 minutes ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of GLGI.OTCQB.

GLGI.OTCQB Daily Candlestick Chart
CCMCUA.SW
33 minutes ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of CCMCUA.SW.

CCMCUA.SW Daily Candlestick Chart
AUVI.NASDAQ
34 minutes ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of AUVI.NASDAQ.

AUVI.NASDAQ Daily Candlestick Chart
AUUD.NASDAQ
34 minutes ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of AUUD.NASDAQ.

AUUD.NASDAQ Daily Candlestick Chart
AUPH.NASDAQ
36 minutes ago

I found you a STOCH Bearish Reversal Divergence on the daily chart of AUPH.NASDAQ.

AUPH.NASDAQ Daily Candlestick Chart
WIB.STU
44 minutes ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of WIB.STU.

WIB.STU Daily Candlestick Chart
WFSTF.PINK
44 minutes ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of WFSTF.PINK.

WFSTF.PINK Daily Candlestick Chart
WEDXF.PINK
45 minutes ago

I found you a Golden Cross on the daily chart of WEDXF.PINK.

WEDXF.PINK Daily Candlestick Chart
WCIG.PINK
46 minutes ago

I found you a STOCH Bearish Reversal Divergence on the daily chart of WCIG.PINK.

WCIG.PINK Daily Candlestick Chart
VISA.NEO
52 minutes ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of VISA.NEO.

VISA.NEO Daily Candlestick Chart
BOTZ.SW
1 hour ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of BOTZ.SW.

BOTZ.SW Daily Candlestick Chart
UPG.BR
1 hour ago

I found you a STOCH Bearish Reversal Divergence on the daily chart of UPG.BR.

UPG.BR Daily Candlestick Chart
ICC.MI
1 hour ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of ICC.MI.

ICC.MI Daily Candlestick Chart
CBUS5.SW
1 hour ago

I found you a Golden Cross on the daily chart of CBUS5.SW.

CBUS5.SW Daily Candlestick Chart
TSLA.NEO
1 hour ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of TSLA.NEO.

TSLA.NEO Daily Candlestick Chart
GASE.PINK
1 hour ago

I found you a RSI Bullish Reversal Divergence on the daily chart of GASE.PINK.

GASE.PINK Daily Candlestick Chart